Persistent myogenic temporomandibular disorders: Are navigation-guided botulinum toxin-A injections into the lateral pterygoid muscles effective?

Fiche publication

Date publication

octobre 2024

Journal

Journal of stomatology, oral and maxillofacial surgery

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MEYER Christophe

Tous les auteurs :
Martenot A, Devoti JF, Pons M, Meyer C, Brumpt E, Louvrier A, Bertin E

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38013116

Résumé

Botulinum toxin has proven effective in treating persistent myogenous temporomandibular disorders (M-TMDs) unresponsive to conservative therapies. While the usual injection sites are the masseter and temporalis muscles, the deeper lateral pterygoid muscle (LPM) is often overlooked due to its difficulty of access and the risk of local complications. This study aims to evaluate the effectiveness of botulinum toxin-A injections (BTX-A) in the LPM with MR-guided navigation of patients with persistent M-TMDs.